NIKI (NIKI) Stock Price & Analysis
NIKI (NIKI) fell 2.33% to USD 8.38 as of July 25, 2026 at 03:03 UTC, according to Nexqual real-time market data.
NIKI last closed at USD 8.58; the session ranged USD 7.8–8.65 on volume of 49,037 shares. Market capitalization is $6.82M, with a 52-week range of USD 6–44.7 (NGM). Source: Nexqual, July 25, 2026 at 03:03 UTC.
Key Statistics (as of July 25, 2026 at 03:03 UTC)
| Price | USD 8.38 |
|---|---|
| Change | ▼ 2.33% (down) |
| Previous Close | USD 8.58 |
| Open | USD 8.35 |
| Day Range | USD 7.8 – 8.65 |
| 52-Week Range | USD 6 – 44.7 |
| Volume | 49,037 shares |
| Market Cap | $6.82M |
| Exchange | NGM |
Technical Analysis (NIKI)
Nexqual's technical model rates NIKI "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 03:03 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.92 (neutral) |
| vs SMA50 | Below (USD 8.63) |
| MACD | -0.02 (negative) |
Analyst Ratings (NIKI)
Wall Street analysts rate NIKI "None", per Nexqual as of July 25, 2026 at 03:03 UTC.
| Consensus Rating | None |
|---|
Earnings (NIKI)
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financials & Fundamentals (NIKI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -10.79% |
| Debt / Equity | 25.05 |
| Current Ratio | 0.78 |
| Total Cash | $3.45M |
| Total Debt | $3.44M |
| Free Cash Flow | $-1.10M |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Financial Health Score (NIKI)
Nexqual rates NIKI's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 03:03 UTC.
| Growth | Critical — Revenue -16% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $3M cash vs $3M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$1M, burning cash |
| Efficiency | Critical — ROE -11%, ROA -6.5% |
Ownership (NIKI)
| Insider Ownership | +3.04% |
|---|---|
| Institutional Ownership | +0.46% |
| Shares Outstanding | 634,682 |
| Float | 535,932 |
| Short % of Float | +1.07% |
Source: Nexqual, July 25, 2026 at 03:03 UTC.
Leadership (NIKI)
NIKI is led by Chung Yuen Huen (age 45), Founder, CEO & Executive Director, per Nexqual as of July 25, 2026 at 03:03 UTC.
| Founder, CEO & Executive Director | Chung Yuen Huen (age 45) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals, Inc | USD 2.78 | ▲ 2.96% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.84 | ▼ 3.01% |
| ATHE | Alterity Therapeutics Limited | USD 4.54 | ▼ 3.4% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.04 | ▼ 1.89% |
| BCDA | BioCardia, Inc. | USD 0.85 | ▼ 6.59% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:03 UTC. This page is informational and not investment advice.